These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20444884)

  • 61. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
    Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
    J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.
    Wei D; Tao R; Zhang Y; White MF; Dong XC
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E312-20. PubMed ID: 21081708
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nuclear receptor SHP dampens transcription function and abrogates mitotic chromatin association of PXR and ERα via intermolecular interactions.
    Kumar S; Vijayan R; Dash AK; Gourinath S; Tyagi RK
    Biochim Biophys Acta Gene Regul Mech; 2021 Mar; 1864(3):194683. PubMed ID: 33444783
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
    Deuschle U; Schüler J; Schulz A; Schlüter T; Kinzel O; Abel U; Kremoser C
    PLoS One; 2012; 7(10):e43044. PubMed ID: 23056173
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circadian rhythmicity: A functional connection between differentiated embryonic chondrocyte-1 (DEC1) and small heterodimer partner (SHP).
    Marczak MM; Yan B
    Arch Biochem Biophys; 2017 Oct; 631():11-18. PubMed ID: 28797635
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
    Matsukuma KE; Bennett MK; Huang J; Wang L; Gil G; Osborne TF
    J Lipid Res; 2006 Dec; 47(12):2754-61. PubMed ID: 16957179
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR.
    Dong B; Singh AB; Guo GL; Young M; Liu J
    Int J Mol Med; 2019 May; 43(5):1927-1938. PubMed ID: 30896855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diurnal regulation of the early growth response 1 (Egr-1) protein expression by hepatocyte nuclear factor 4alpha (HNF4alpha) and small heterodimer partner (SHP) cross-talk in liver fibrosis.
    Zhang Y; Bonzo JA; Gonzalez FJ; Wang L
    J Biol Chem; 2011 Aug; 286(34):29635-43. PubMed ID: 21725089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
    J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tissue specific induction of p62/Sqstm1 by farnesoid X receptor.
    Williams JA; Thomas AM; Li G; Kong B; Zhan L; Inaba Y; Xie W; Ding WX; Guo GL
    PLoS One; 2012; 7(8):e43961. PubMed ID: 22952826
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes.
    Rizzo G; Renga B; Antonelli E; Passeri D; Pellicciari R; Fiorucci S
    Mol Pharmacol; 2005 Aug; 68(2):551-8. PubMed ID: 15911693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of the Farnesoid X Receptor (FXR) Suppresses Linoleic Acid-Induced Inflammation in the Large Yellow Croaker (Larimichthys crocea).
    Du J; Chen Q; Li Y; Xiang X; Xu W; Mai K; Ai Q
    J Nutr; 2020 Sep; 150(9):2469-2477. PubMed ID: 32614453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription.
    Chen WD; Wang YD; Zhang L; Shiah S; Wang M; Yang F; Yu D; Forman BM; Huang W
    Hepatology; 2010 Mar; 51(3):953-62. PubMed ID: 19998409
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation.
    Nishizawa H; Yamagata K; Shimomura I; Takahashi M; Kuriyama H; Kishida K; Hotta K; Nagaretani H; Maeda N; Matsuda M; Kihara S; Nakamura T; Nishigori H; Tomura H; Moore DD; Takeda J; Funahashi T; Matsuzawa Y
    J Biol Chem; 2002 Jan; 277(2):1586-92. PubMed ID: 11696534
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activation of FXR promotes intestinal metaplasia of gastric cells via SHP-dependent upregulation of the expression of CDX2.
    Zhou H; Ni Z; Li T; Su L; Zhang L; Liu N; Shi Y
    Oncol Lett; 2018 May; 15(5):7617-7624. PubMed ID: 29849798
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
    Handelman SK; Puentes YM; Kuppa A; Chen Y; Du X; Feitosa MF; Palmer ND; Speliotes EK
    Hepatol Commun; 2022 Nov; 6(11):3120-3131. PubMed ID: 36098472
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR.
    Chong HK; Biesinger J; Seo YK; Xie X; Osborne TF
    BMC Genomics; 2012 Feb; 13():51. PubMed ID: 22296850
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.
    Chong HK; Infante AM; Seo YK; Jeon TI; Zhang Y; Edwards PA; Xie X; Osborne TF
    Nucleic Acids Res; 2010 Oct; 38(18):6007-17. PubMed ID: 20483916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.